
Nancy Perrier, MD, FACS, is a tenured surgical oncologist and a Ruth and Walter Sterling Endowed professor in the Department of Surgical Oncology at MD Anderson Cancer Center, where she leads the Section of Surgical Endocrinology as chief and is associate medical director of the Multidisciplinary Endocrine Center. The section sees a high volume of patients and is regarded for excellent outcomes, nationally funded research, a top tier fellowship and is the hub of training endocrine surgery for fellows in Surgical Oncology, Surgical Endocrinology, Endocrine Neoplasia and General Surgery from several institutions. In addition, with Dr. Perrier at the helm, the program has grown to include multidisciplinary translational research platforms and international research trainees who extend onto productive academic and clinical surgical careers. The investigative and translation efforts have led to the development of robust multidisciplinary platforms for sporadic and hereditary endocrine neoplasias. The team has brought together an international collaborative group with the aim of identifying prognostic factors and novel therapeutics for personalized care.
Dr. Perrier’s scholarly works, comprising more than 360 peer reviewed publications and 42 book chapters, are largely related to her international expertise in endocrine surgery, interest in value of care and best care algorithms. Dr Perrier has received a Master’s in Healthcare Management from Rice University’s Graduate School of Business. She is highly regarded among her peers for clinical excellence, integrity, initiative, effectiveness and leadership skills. She serves in multiple capacities at MD Anderson- including value initiatives. She is a Master Surgeon Educator, Governor of the American College of Surgeons. Nationally, her influence extends across multiple organizations where she has served on the board.
Selected publications from PubMed
Genetic endocrine tumors focusing on the thyroid.
Ginzberg SP, Weller JHD, Skefos CM, Perrier ND
Best Pract Res Clin Endocrinol Metab. 2026 Aug 16;:102158 doi: 10.1016/j.beem.2026.102158.
Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.
Liu JB, Yamashita TS, Rollins JL, Lee-Kim SH, Avula KC, Chacko R, Peek A, Williams LA, Zafereo ME, Maniakas A, Wang JR, Busaidy NL, Cabanillas ME, Castellanos LE, Chaudhri A, Dadu R, Hu MI, Vasquez CJ, Ying AK, Varghese JM, Sherman SI, Waguespack SG, Weitzman SP, Graham PH, Perrier ND, Shinn EH, Roth ME, Habra MA, Grubbs EG, Fisher SB
JCO Clin Cancer Inform. 2026 Jul;10(3):e2600041 doi: 10.1200/CCI-26-00041.
Hypoparathyroidism Post Thyroidectomy: Prevention, Evaluation, Management, and Application of Recent Guidelines.
Ali DS, Perrier ND, Khan AA
Thyroid. 2026 Jun;36(6):582-596 doi: 10.1177/10507256261454145.
Blood-Based Immunoglobulin-Bound Neoantigen Signatures Associated with MEN Type 1-Related Duodenopancreatic Neuroendocrine Tumor Progression.
Katayama H, Fahrmann JF, Olsen C, Irajizad E, Cai Y, Hsiao F, Dennison JB, Perrier ND, Hanash SM, MEN1 Consortium
J Am Coll Surg. 2026 Apr 1;242(4):834-842 doi: 10.1097/XCS.0000000000001782.
The shifting landscape of germline RET pathogenic variants with the introduction of panel testing.
Onuma AE, Skefos CM, Richardson ME, Pasyar S, Fergus KB, Bassett RL, Hu MI, Perrier ND, Maniakas A, Zafereo M, Waguespack SG, Sosa JA, Grubbs EG
Surgery. 2026 Jan;189:109701 doi: 10.1016/j.surg.2025.109701.
Help your network discover Dr. Nancy D. Perrier's clinical expertise.